Attovia Therapeutics
$24.66
12
+$0.46+1.9% 12:15 Today
Statistics
Day High
24.48
Day Low
24.24
52W High
26.07
52W Low
16.15
Volume
6,914
Avg. Volume
-
Mkt Cap
1.04B
P/E Ratio
0
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Nov 17
$1.71
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
2DecExpected
Q4 2022
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q2 2026
Next
-2.84
-1.76
-0.68
0.4
Expected EPS
-0.55586
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-18.66MNet Income
Analyst Ratings
42.20Average Price Target
The highest estimate is 52.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ATTO. It's not an investment recommendation.
WM Technology
4
MAPS
OPAL Fuels
4
OPAL
Schwab US Dividend Equity
3
SCHD
Invesco KBW High Dividend Yield Financial
3
KBWD
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Commercial Services
Miscellaneous Commercial Services
Professional, Scientific, and Technical Services
Commercial Photography
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.
Show more...
CEO
Dimitrius Oliveira
Employees
44
Country
United States
ISIN
US04987L1026
WKN
000A2QAN7
Listings
0 Comments
Share your thoughts
FAQ
What is Attovia Therapeutics stock price today?▼
The current price of ATTO is $24.66 USD — it has increased by +1.9% in the past 24 hours. Watch Attovia Therapeutics stock price performance more closely on the chart.
What is Attovia Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Attovia Therapeutics stocks are traded under the ticker ATTO.
What is Attovia Therapeutics market cap?▼
Today Attovia Therapeutics has the market capitalization of 1.04B
When is the next Attovia Therapeutics earnings date?▼
Attovia Therapeutics is going to release the next earnings report on December 02, 2026.
What were Attovia Therapeutics earnings last quarter?▼
ATTO earnings for the last quarter are -2.84 USD per share, whereas the estimation was -0.65 USD resulting in a -339.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Attovia Therapeutics revenue for the last year?▼
Attovia Therapeutics revenue for the last year amounts to 0 USD.
What is Attovia Therapeutics net income for the last year?▼
ATTO net income for the last year is -18.66M USD.
Does Attovia Therapeutics pay dividends?▼
Yes, ATTO dividends are paid en. The last dividend per share was 1.71 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Attovia Therapeutics have?▼
As of September 04, 2026, the company has 44 employees.
In which sector is Attovia Therapeutics located?▼
Attovia Therapeutics operates in the Manufacturing sector.
When did Attovia Therapeutics complete a stock split?▼
The last stock split for Attovia Therapeutics was on July 30, 2020 with a ratio of 1:5.0270904666729.
Where is Attovia Therapeutics headquartered?▼
Attovia Therapeutics is headquartered in Luxembourg, United States.